124 related articles for article (PubMed ID: 31933717)
1. The clinical significance of CHEK1 in breast cancer: a high-throughput data analysis and immunohistochemical study.
Wu M; Pang JS; Sun Q; Huang Y; Hou JY; Chen G; Zeng JJ; Feng ZB
Int J Clin Exp Pathol; 2019; 12(1):1-20. PubMed ID: 31933717
[TBL] [Abstract][Full Text] [Related]
2. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
Yang X; Pan Y; Qiu Z; Du Z; Zhang Y; Fa P; Gorityala S; Ma S; Li S; Chen C; Wang H; Xu Y; Yan C; Ruth K; Ma Z; Zhang J
Clin Cancer Res; 2018 Apr; 24(7):1629-1643. PubMed ID: 29326282
[No Abstract] [Full Text] [Related]
3. Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients.
Ebili HO; Iyawe VO; Adeleke KR; Salami BA; Banjo AA; Nolan C; Rakha E; Ellis I; Green A; Agboola AOJ
Mol Diagn Ther; 2018 Feb; 22(1):79-90. PubMed ID: 29075961
[TBL] [Abstract][Full Text] [Related]
4. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
5. Gene Expression Alterations and Molecular Analysis of CHEK1 in Solid Tumors.
Fadaka AO; Bakare OO; Sibuyi NRS; Klein A
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32178478
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells.
Gali-Muhtasib H; Kuester D; Mawrin C; Bajbouj K; Diestel A; Ocker M; Habold C; Foltzer-Jourdainne C; Schoenfeld P; Peters B; Diab-Assaf M; Pommrich U; Itani W; Lippert H; Roessner A; Schneider-Stock R
Cancer Res; 2008 Jul; 68(14):5609-18. PubMed ID: 18632613
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients.
Leaf S; Carlsen L; El-Deiry WS
Oncotarget; 2021 Sep; 12(20):1992-2005. PubMed ID: 34611475
[TBL] [Abstract][Full Text] [Related]
8. Network Meta-Analysis on the Effects of DNA Damage Response-Related Gene Mutations on Overall Survival of Breast Cancer Based on TCGA Database.
Liu C; Chang H; Li XH; Qi YF; Wang JO; Zhang Y; Yang XH
J Cell Biochem; 2017 Dec; 118(12):4728-4734. PubMed ID: 28513990
[TBL] [Abstract][Full Text] [Related]
9. Prospective molecular mechanism of COL5A1 in breast cancer based on a microarray, RNA sequencing and immunohistochemistry.
Wu M; Sun Q; Mo CH; Pang JS; Hou JY; Pang LL; Lu HP; Dang YW; Fang SJ; Tang D; Chen G; Feng ZB
Oncol Rep; 2019 Jul; 42(1):151-175. PubMed ID: 31059074
[TBL] [Abstract][Full Text] [Related]
10. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
11. [CHEK1 expression and inhibitors in TP53 mutant cancer].
Õsz Á; Aszódi B; Vajda R; Keserû MG; Moll HP; Casanova E; Gyõrffy B
Magy Onkol; 2019 Dec; 63(4):345-352. PubMed ID: 31821389
[TBL] [Abstract][Full Text] [Related]
12. Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
Gangadharan A; Nyirenda T; Patel K; Jaimes-Delgadillo N; Coletta D; Tanaka T; Walland AC; Jameel Z; Vedantam S; Tang S; Mannion C; Lee GY; Goy A; Pecora A; Suh KS
Breast; 2018 Jun; 39():101-109. PubMed ID: 29656222
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in CHEK1 gene are associated with the prognosis of thoracic esophageal squamous cell carcinoma patients treated with radical resection.
Li J; Tang Y; Huang L; Yu QQ; Hu GY; Chen C; Zhang P; Yuan XL
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):828-833. PubMed ID: 27924519
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
[TBL] [Abstract][Full Text] [Related]
15. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
16. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
[TBL] [Abstract][Full Text] [Related]
17. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
19. Case report: A germline
Qian J; Peng M; Li Y; Liu W; Zou X; Chen H; Zhou S; Xiao S; Zhou J
Front Oncol; 2024; 14():1380093. PubMed ID: 38686193
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
Petrelli F; Viale G; Cabiddu M; Barni S
Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
